Cargando…

ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans

BACKGROUND: Rare coding variants ABI3_rs616338-T and PLCG2_rs72824905-G were identified as risk or protective factors, respectively, for Alzheimer’s disease (AD). METHODS: We tested the association of these variants with five neurodegenerative diseases in Caucasian case-control cohorts: 2742 AD, 231...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conway, Olivia J, Carrasquillo, Minerva M, Wang, Xue, Bredenberg, Jenny M, Reddy, Joseph S, Strickland, Samantha L, Younkin, Curtis S, Burgess, Jeremy D, Allen, Mariet, Lincoln, Sarah J, Nguyen, Thuy, Malphrus, Kimberly G, Soto, Alexandra I, Walton, Ronald L, Boeve, Bradley F, Petersen, Ronald C, Lucas, John A, Ferman, Tanis J, Cheshire, William P, van Gerpen, Jay A, Uitti, Ryan J, Wszolek, Zbigniew K, Ross, Owen A, Dickson, Dennis W, Graff-Radford, Neill R, Ertekin-Taner, Nilüfer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190665/ https://www.ncbi.nlm.nih.gov/pubmed/30326945 http://dx.doi.org/10.1186/s13024-018-0289-x

Ejemplares similares

Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy
por: Strickland, Samantha L., et al.
Publicado: (2020)

ABCA7 loss-of-function variants, expression, and neurologic disease risk
por: Allen, Mariet, et al.
Publicado: (2017)

Abnormal daytime sleepiness in dementia with Lewy bodies compared to Alzheimer’s disease using the Multiple Sleep Latency Test
por: Ferman, Tanis J, et al.
Publicado: (2014)

LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer’s Disease (LOAD)
por: Lincoln, Sarah, et al.
Publicado: (2013)

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
por: van der Lee, Sven J., et al.
Publicado: (2019)

Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy
por: Allen, Mariet, et al.
Publicado: (2018)

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
por: van der Lee, Sven J., et al.
Publicado: (2020)

Late-onset Alzheimer disease risk variants mark brain regulatory loci
por: Allen, Mariet, et al.
Publicado: (2015)

Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

TREM2 p.R47H substitution is not associated with dementia with Lewy bodies
por: Walton, Ronald L., et al.
Publicado: (2016)

African American exome sequencing identifies potential risk variants at Alzheimer disease loci
por: N'Songo, Aurelie, et al.
Publicado: (2017)

Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications
por: Allen, Mariet, et al.
Publicado: (2012)

Latent trait modeling of tau neuropathology in progressive supranuclear palsy
por: Kouri, Naomi, et al.
Publicado: (2021)

Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer’s disease brains
por: Ma, Li, et al.
Publicado: (2016)

Plasma Biomarkers of Alzheimer’s Disease in African Americans
por: Deniz, Kaancan, et al.
Publicado: (2021)

TMEM106B haplotypes have distinct gene expression patterns in aged brain
por: Ren, Yingxue, et al.
Publicado: (2018)

Clinical Deep Phenotyping of ABCA7 Mutation Carriers
por: Campbell, Alana S., et al.
Publicado: (2022)

Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s disease
por: Dalmasso, Maria Carolina, et al.
Publicado: (2019)

When DLB, PD, and PSP masquerade as MSA: An autopsy study of 134 patients
por: Koga, Shunsuke, et al.
Publicado: (2015)

Comparative evaluation for the globin gene depletion methods for mRNA sequencing using the whole blood-derived total RNAs
por: Jang, Jin Sung, et al.
Publicado: (2020)

Alzheimer’s disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions
por: Wang, Xue, et al.
Publicado: (2022)

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
por: Medway, Christopher W, et al.
Publicado: (2014)

Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
por: Ibanez, Kristen R., et al.
Publicado: (2022)

Recurrent PTPRB and PLCG1 mutations in angiosarcoma
por: Behjati, Sam, et al.
Publicado: (2014)

Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African Americans
por: Reddy, Joseph S., et al.
Publicado: (2022)

MAPT haplotype–stratified GWAS reveals differential association for AD risk variants
por: Strickland, Samantha L., et al.
Publicado: (2020)

Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s disease
por: Reddy, Joseph S., et al.
Publicado: (2021)

Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases
por: Allen, Mariet, et al.
Publicado: (2016)

Gene expression endophenotypes: a novel approach for gene discovery in Alzheimer's disease
por: Ertekin-Taner, Nilüfer
Publicado: (2011)

Genetics of Alzheimer disease in the pre- and post-GWAS era
por: Ertekin-Taner, Nilüfer
Publicado: (2010)

Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures
por: Valentino, Rebecca R., et al.
Publicado: (2022)

Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants
por: Zou, Fanggeng, et al.
Publicado: (2012)

Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels
por: Allen, Mariet, et al.
Publicado: (2014)

Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease
por: Li, Hong‐Dong, et al.
Publicado: (2021)

Association study between multiple system atrophy and TREM2 p.R47H
por: Ogaki, Kotaro, et al.
Publicado: (2018)

Association of MAPT subhaplotypes with clinical and demographic features in Parkinson’s disease
por: Deutschlander, Angela B., et al.
Publicado: (2020)

Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studies
por: Wickland, Daniel P., et al.
Publicado: (2021)

Evaluation of the Role of SNCA Variants in Survival without Neurological Disease
por: Heckman, Michael G., et al.
Publicado: (2012)

PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer’s disease
por: Tsai, Andy P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ui628sagu7a3q0hlv12e905nbi